US 10570169
Conjugated antisense compounds and their use
granted A61KA61K39/00
Quick answer
US patent 10570169 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K39/00